Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Government Must Do More for Science Says New Research

Published: Friday, July 12, 2013
Last Updated: Friday, July 12, 2013
Bookmark and Share
The UK’s science-based economy needs greater support from the Government according to new research undertaken by Lab Innovations, the UK’s only event dedicated to the laboratory industries.

62% of directors and senior decision makers from over 112 scientific UK organisations say the UK Government isn’t doing enough to support them.

The list of government actions the companies call for include: greater investment to support key research projects, helping attract overseas investment in R&D, providing tax incentives for research, reducing taxes on manufacturing, science and technology companies and to allow more genuine foreign workers and students into the UK.

The 112 companies who participated in the survey cover the broad spectrum of science business sectors from biotech businesses, pharmaceutical companies, life science and environmental organisations through to research institutions plus healthcare, food, drink, chemical and petrochemical companies with extensive R&D teams.
 
The research suggests these science-based organisations are playing a crucial part of the UK economy.  For instance, 38% of those taking part employ over 100 people, with 17 companies employing over 500. The vast majority, (86%) are exporters, with on average 35% of sales going to overseas markets.  While two thirds of companies  are focused on selling into the EU and over a third (36%) to North America, many are pushing into vital emerging markets such as China (31%), India (21%) and Africa (16%).

According to the research, recent developments such as the weakness of sterling, have helped 16% to export more, however those surveyed are facing some major barriers which are inhibiting their success.  The biggest challenge is a lack of finance for R&D which is cited by 35%; a lack of finance for investment is also a major barrier afflicting 27%. Over one in five (23%) say too much red tape and regulation is holding them back, a similar number (22%) say growth is being inhibited by a lack of a skilled workforce.

While the Government has introduced initiatives to free up finance and talks about the importance of science, technology, engineering and mathematics (STEM), only 25% of the companies questioned believe the Government is genuine in its desire to rebalance the economy away from finance and services, and towards more STEM based activity.  Almost a third (31%) are unsure how serious the Government is with regards to this policy, and the largest group (44%) do not believe this is a genuine objective at all.

The companies studied face plenty of market opportunity, barely 6% say a lack of overseas demand is an issue, and few find it difficult to target overseas markets, but with almost one in five (19%) worried about even financing day-to-day activities, there is clearly an argument that greater finance is required if these important players in the UK economy are to reach their potential.

Commenting on the results of this survey, Jake Morrison, Lab Innovations event manager, says: “The UK has a tremendous scientific reputation, and the companies participating in the survey are thriving and extremely optimistic. Their mindset is on growth, and both within the UK and beyond.

“However there is clearly a lot of untapped potential within these companies which they want to unlock.  They are also highly dependent on R&D and future growth will only come from both research and expansion which requires investment.”

These will be just some of the topics debated on and around the show floor at this year’s Lab Innovations 2013 held at the NEC, Birmingham on the 6 & 7 November.  New for 2013, Lab Innovations will feature a dynamic panel debate hosted by The Royal Society of Chemistry giving industry experts and attendees to the show the opportunity to discuss the critical issues affecting the sector.

Lab Innovations 2013 will also feature over 100 exhibitors plus a conference programme featuring renowned keynote speakers and sessions organised by the Royal Society of Chemistry, plus practical workshops delivered by Campden BRI.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Launches and Innovation at LAB INNOVATIONS 2012
Supported by The Royal Society of Chemistry, LAB INNOVATIONS is the UK’s only event dedicated to showcasing the latest laboratory technology & consumables, analytical & biotech equipment.
Wednesday, July 25, 2012
Scientific News
Combining Chemotherapy With Immune-Blocking Drug Could Stop Cancer Growing Back
Giving patients a drug that blocks part of the immune system from going into overdrive might help prevent cancer coming back in some people.
Researchers Pioneer Use of Capsules to Save Materials
Wax capsule delivery systems can simplify a wide range of chemistry transformations.
Photoredox Catalyst Unlocks New Pathways for Nickel Chemistry
Using a light-activated catalyst, researchers have unlocked a new pathway in nickel chemistry to construct carbon-oxygen (C-O) bonds that would be highly valuable to pharmaceutical and agrochemical industries.
Scientists Determine How Antibiotic Gains Cancer-Killing Sulfur Atoms
In a discovery with implications for future drug design scientists have shown an unprecedented mechanism for how a natural antibiotic with antitumor properties incorporates sulfur into its molecular structure, an essential ingredient of its antitumor activity.
Familiar Drugs May Block Ebola Virus Infection
A well-known class of molecules, many of which are already in use therapeutically, may be able to block the Ebola virus’s entry into cells and halt the disease in its tracks, according to researchers at the University of Illinois at Chicago.
New Extra ‘Sticky’ Microgel Could Revolutionise Bladder Cancer Treatment
Researchers have designed a new super-efficient way of delivering an anti-cancer drug which could extend and improve the quality of life for bladder cancer patients - and perhaps save lives.
Common Class of ‘Channel Blocking’ Drugs May Find a Role in Cancer Therapy
Discoveries in fruit flies prompt unusual treatment of patient with metastatic disease.
Common Medications Could Delay Brain Injury Recovery
Drugs used to treat common complaints could delay the recovery of brain injury patients according to research by University of East Anglia (UEA) and University of Aberdeen scientists, published today in Brain Injury.
Scientists Make Strides in Therapy Preventing Addiction Relapse
Single Injection of Drug Candidate Prevents Meth Relapse in Animal Models.
New Clot-Busting Treatments Target Number One Killer
Australian researchers funded by the National Heart Foundation are a step closer to a safer and more effective way to treat heart attack and stroke via nanotechnology.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!